Dexmedetomidine. Pharmacokinetics and pharmacodynamics;Dexmedetomidin: Pharmakokinetik und Pharmakodynamik

Anaesthesist

Volumn 61, Issue 12, 2012, Pages 1059-1066

  Ihmsen, H ^a   Saari, T I ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Adults; Analgesia; Children; Intensive care; Sedation

Indexed keywords

DEXMEDETOMIDINE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; HYPNOTIC SEDATIVE AGENT;

ARTICLE; HUMAN; INTENSIVE CARE UNIT; OFF LABEL DRUG USE; PHARMACODYNAMICS; SEDATION; TRANQUILIZING ACTIVITY; ADULT; CHILD; CONSCIOUS SEDATION; DRUG INTERACTION; INTENSIVE CARE; INTESTINE ABSORPTION; REVIEW;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADULT; ANALGESICS, NON-NARCOTIC; CHILD; CONSCIOUS SEDATION; DEXMEDETOMIDINE; DRUG INTERACTIONS; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; INTESTINAL ABSORPTION;

EID: 84878188046     PISSN: 00032417     EISSN: 1432055X     Source Type: Journal    
DOI: 10.1007/s00101-012-2114-1     Document Type: Article

References (50)

1. Albrecht S, Ihmsen H, Hering W et al (1999) The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther 65:630-639
2. Anttila M, Penttila J, Helminen A et al (2003) Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol 56:691-693
3. Bach A, Motsch J, Schmidt H et al (1997) In-use contamination of propofol. A clinical study. Eur J Anaesthesiol 14:178-183
4. Blaine Easley R, Brady KM, Tobias JD (2007) Dexmedetomidine for the treatment of postanesthesia shivering in children. Paediatr Anaesth 17:341-346
5. Buck ML (2010) Dexmedetomidine use in pediatric intensive care and procedural sedation. J Pediatr Pharmacol Ther 15:17-29
6. Buhrer M, Mappes A, Lauber R et al (1994) Dexmedetomidine decreases thiopental dose requirement and alters distribution pharmacokinetics. Anesthesiology 80:1216-1227
7. Cortinez LI, Hsu YW, Sum-Ping ST et al (2004) Dexmedetomidine pharmacodynamics: Part II: crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 101:1077-1083
8. Czaja AS, Zimmerman JJ (2009) The use of dexmedetomidine in critically ill children. Pediatr Crit Care Med 10:381-386
9. De Wolf AM, Fragen RJ, Avram MJ et al (2001) The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg 93:1205-1209
10. Devlin JW, Lau AK, Tanios MA (2005) Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors. Pharmacotherapy 25:1348-1352
11. Devlin JW, Mallow-Corbett S, Riker RR (2010) Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med 38:231-243
12. Diedrich DA, Brown DR (2011) Analytic reviews: propofol infusion syndrome in the ICU. J Intensive Care Med 26:59-72
13. Dutta S, Lal R, Karol MD et al (2000) Influence of cardiac output on dexmedetomidine pharmacokinetics. J Pharm Sci 89:519-527
14. Dyck JB, Maze M, Haack C et al (1993) Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology78:821-828
15. Dyck JB, Maze M, Haack C et al (1993) The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 78:813-820
16. Ebert TJ, Hall JE, Barney JA et al (2000) The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93:382-394
17. Elvan EG, Oc B, Uzun S et al (2008) Dexmedetomidine and postoperative shivering in patients undergoing elective abdominal hysterectomy. Eur J Anaesthesiol 25:357-364
18. Fragen RJ (1997) Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units. Clin Ther 19:405-419, discussion 367-408
19. Hosokawa K, Shime N, Kato Y et al (2010) Dexmedetomidine sedation in children after cardiac surgery. Pediatr Crit Care Med 11:39-43
20. Huupponen E, Maksimow A, Lapinlampi P et al (2008) Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol Scand 52:289-294
21. Iirola T, Ihmsen H, Laitio R et al (2012) Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients. Br J Anaesth 108:460-468
22. Iirola T, Vilo S, Aantaa R et al (2011) Dexmedetomidine inhibits gastric emptying and oro-caecal transit in healthy volunteers. Br J Anaesth 106:522-527
23. Jakob SM, Ruokonen E, Grounds RM et al (2012) Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 307:1151-1160
24. Jansson CC, Pohjanoksa K, Lang J et al (1999) Alpha2-adrenoceptor agonists stimulate high-affinity GTPase activity in a receptor subtype-selective manner. Eur J Pharmacol 374:137-146
25. Karol MD, Maze M (2000) Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans. Baillieres Best Pract Res Clin Anaesthesiol 14:261-269
26. Kauppila T, Kemppainen P, Tanila H et al (1991) Effect of systemic medetomidine, an alpha 2 adrenoceptor agonist, on experimental pain in humans. Anesthesiology 74:3-8
27. Kharasch ED, Hill HF, Eddy AC (1991) Influence of dexmedetomidine and clonidine on human liver microsomal alfentanil metabolism. Anesthesiology 75:520-524
28. Kivisto KT, Kallio A, Neuvonen PJ (1994) Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine. Eur J Clin Pharmacol 46:345-349
29. Kohli U, Muszkat M, Sofowora GG et al (2010) Effects of variation in the human alpha2A- and alpha2C-adrenoceptor genes on cognitive tasks and pain perception. Eur J Pain 14:154-159
30. Lin L, Guo X, Zhang MZ et al (2011) Pharmacokinetics of dexmedetomidine in Chinese post-surgical intensive care unit patients. Acta Anaesthesiol Scand 55:359-367
31. Lin TF, Yeh YC, Lin FS et al (2009) Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia. Br J Anaesth 102:117-122
32. Link RE, Desai K, Hein L et al (1996) Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 273:803-805
33. Marsh B, White M, Morton N et al (1991) Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 67:41-48
34. Martin J, Franck M, Sigel S et al (2007) Changes in sedation management in German intensive care units between 2002 and 2006: a national follow-up survey. Crit Care 11:R124
35. Martin J, Parsch A, Franck M et al (2005) Practice of sedation and analgesia in German intensive care units: results of a national survey. Crit Care 9: R117-123
36. McKeage K, Perry CM (2003) Propofol: a review of its use in intensive care sedation of adults. CNS Drugs 17:235-272
37. Memis D, Dokmeci D, Karamanlioglu B et al (2006) A comparison of the effect on gastric emptying of propofol or dexmedetomidine in critically ill patients: preliminary study. Eur J Anaesthesiol 23:700-704
38. Muellejans B, Matthey T, Scholpp J et al (2006) Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial. Crit Care 10:R91
39. Nelson LE, Lu J, Guo T et al (2003) The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 98:428-436
40. Pichot C, Ghignone M, Quintin L (2012) Dexmedetomidine and clonidine: from second- to first-line sedative agents in the critical care setting? J Intensive Care Med 27:219-237
41. Potts AL, Anderson BJ, Warman GR et al (2009) Dexmedetomidine pharmacokinetics in pediatric intensive care-a pooled analysis. Paediatr Anaesth 19:1119-1129
42. Riker RR, Shehabi Y, Bokesch PM et al (2009) Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 301:489-499
43. Sessler CN, Gosnell MS, Grap MJ et al (2002) The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 166:1338-1344
44. Talke P, Richardson CA, Scheinin M, Fisher DM (1997) Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 85:1136-1142
45. Tan JA, Ho KM (2010) Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med 36:926-939
46. Venn RM, Bradshaw CJ, Spencer R et al (1999) Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 54:1136-1142
47. Venn RM, Grounds RM (2001) Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 87:684-690
48. Venn RM, Hell J, Grounds RM (2000) Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 4:302-308
49. Venn RM, Karol MD, Grounds RM (2002) Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 88:669-675
50. Virtanen R, Savola JM, Saano V et al (1988) Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol 150:9-14